General
Preferred name
LEVODROPROPIZINE
Synonyms
(S)-(-)-Dropropizine ()
DF-526 ()
(S)-(-)-Dropropizine,DF-526 ()
L-dropropizine ()
(-)-dropropizine ()
Danka ()
Levotuss ()
Rapitux ()
Levopront ()
Dropropizine, (s)- ()
Dropropizine s-form ()
Dipropizine, (s)-isomer ()
P&D ID
PD011984
CAS
99291-25-5
Tags
natural product
drug
available
Drug Status
investigational
approved
Max Phase
Phase 3
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
11
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
NPC Screening Collection
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
29
Properties
(calculated by RDKit )
Molecular Weight
236.15
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
4
Ring Count
2
Aromatic Ring Count
1
cLogP
0.16
TPSA
46.94
Fraction CSP3
0.54
Chiral centers
1.0
Largest ring
6.0
QED
0.78
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
GPCR/G protein
Neuroscience
Immunology/Inflammation
Neuronal Signaling
Target
HT
Histamine Receptor
Indication
cough suppressant
MOA
antitussive
Source data
